Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 335

Similar articles for PubMed (Select 23406689)

1.

MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.

Assenza GE, Graham DA, Landzberg MJ, Valente AM, Singh MN, Bashir A, Fernandes S, Mortele KJ, Ukomadu C, Volpe M, Wu F.

Heart. 2013 Apr;99(7):491-6. doi: 10.1136/heartjnl-2012-303347. Epub 2013 Feb 13.

PMID:
23406689
2.

Outcomes after transplantation for "failed" Fontan: a single-institution experience.

Davies RR, Sorabella RA, Yang J, Mosca RS, Chen JM, Quaegebeur JM.

J Thorac Cardiovasc Surg. 2012 May;143(5):1183-1192.e4. doi: 10.1016/j.jtcvs.2011.12.039.

PMID:
22500594
3.

Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.

Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.

Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.

PMID:
22410024
4.

Orthotopic heart transplantation in patients with univentricular physiology.

Michielon G, Carotti A, Pongiglione G, Cogo P, Parisi F.

Curr Cardiol Rev. 2011 May;7(2):85-91. doi: 10.2174/157340311797484259. Review.

5.

Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.

Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, Mancini DM, Schulze PC.

J Am Coll Cardiol. 2013 Jun 4;61(22):2253-61. doi: 10.1016/j.jacc.2012.12.056. Epub 2013 Apr 3.

6.

Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery.

Tsuda K, Koide M, Kunii Y, Watanabe K, Miyairi S, Ohashi Y, Harada T.

Interact Cardiovasc Thorac Surg. 2013 May;16(5):630-5. doi: 10.1093/icvts/ivt014. Epub 2013 Feb 12.

7.

Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients.

Diller GP, Giardini A, Dimopoulos K, Gargiulo G, Müller J, Derrick G, Giannakoulas G, Khambadkone S, Lammers AE, Picchio FM, Gatzoulis MA, Hager A.

Eur Heart J. 2010 Dec;31(24):3073-83. doi: 10.1093/eurheartj/ehq356. Epub 2010 Oct 7.

8.

Bidirectional cavopulmonary shunt with additional pulmonary blood flow: a failed or successful strategy?

Gérelli S, Boulitrop C, Van Steenberghe M, Maldonado D, Bojan M, Raisky O, Sidi D, Vouhé PR.

Eur J Cardiothorac Surg. 2012 Sep;42(3):513-9. doi: 10.1093/ejcts/ezs053. Epub 2012 Feb 24.

PMID:
22368190
9.

Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.

Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, Mancini DM, Naka Y, Schulze PC.

J Heart Lung Transplant. 2012 Jun;31(6):601-10. doi: 10.1016/j.healun.2012.02.027. Epub 2012 Mar 28.

10.

Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.

Deo SV, Daly RC, Altarabsheh SE, Hasin T, Zhao Y, Shah IK, Stulak JM, Boilson BA, Schirger JA, Joyce LD, Park SJ.

ASAIO J. 2013 Jan-Feb;59(1):57-62. doi: 10.1097/MAT.0b013e31827c0c77.

PMID:
23263341
11.

Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.

Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T, Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC.

J Heart Lung Transplant. 2012 Jun;31(6):591-600. doi: 10.1016/j.healun.2012.02.008. Epub 2012 Mar 27.

12.

Is heart transplantation for complex congenital heart disease a good option? A 25-year single centre experience.

Seddio F, Gorislavets N, Iacovoni A, Cugola D, Fontana A, Galletti L, Terzi A, Ferrazzi P.

Eur J Cardiothorac Surg. 2013 Mar;43(3):605-11; discussion 611. doi: 10.1093/ejcts/ezs350. Epub 2012 Jun 24.

PMID:
22733841
13.

Use of the model for end-stage liver disease score for guiding clinical decision-making in the selection of patients for emergency cardiac transplantation.

Vanhuyse F, Maureira P, Mattei MF, Laurent N, Folliguet T, Villemot JP.

Eur J Cardiothorac Surg. 2013 Jul;44(1):134-8. doi: 10.1093/ejcts/ezs713. Epub 2013 Jan 22.

PMID:
23345182
14.

Composite risk factors predict survival after transplantation for congenital heart disease.

Kavarana MN, Savage A, O'Connell R, Rubinstein CS, Flynn-Reeves J, Joshi K, Stroud MR, Ikonomidis JS, Bradley SM.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):888-93. doi: 10.1016/j.jtcvs.2013.06.016. Epub 2013 Jul 22.

PMID:
23886031
15.

The modern Fontan operation shows no increase in mortality out to 20 years: a new paradigm.

Dabal RJ, Kirklin JK, Kukreja M, Brown RN, Cleveland DC, Eddins MC, Lau Y.

J Thorac Cardiovasc Surg. 2014 Dec;148(6):2517-23.e1. doi: 10.1016/j.jtcvs.2014.07.075. Epub 2014 Aug 4.

PMID:
25277471
16.

Long-term outcomes of common atrioventricular valve plasty in patients with functional single ventricle.

Misumi Y, Hoashi T, Kagisaki K, Kitano M, Kurosaki K, Shiraishi I, Yagihara T, Ichikawa H.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):259-65. doi: 10.1093/icvts/ivt508. Epub 2013 Dec 12.

17.

Heart transplantation in patients with previous Fontan operations.

Gamba A, Merlo M, Fiocchi R, Terzi A, Mammana C, Sebastiani R, Ferrazzi P.

J Thorac Cardiovasc Surg. 2004 Feb;127(2):555-62.

PMID:
14762368
18.

Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients.

Voeller RK, Epstein DJ, Guthrie TJ, Gandhi SK, Canter CE, Huddleston CB.

Ann Thorac Surg. 2012 Sep;94(3):807-15; discussion 815-6. doi: 10.1016/j.athoracsur.2012.02.052. Epub 2012 May 26.

PMID:
22632881
19.

Model for end-stage liver disease predicts mortality for tricuspid valve surgery.

Ailawadi G, Lapar DJ, Swenson BR, Siefert SA, Lau C, Kern JA, Peeler BB, Littlewood KE, Kron IL.

Ann Thorac Surg. 2009 May;87(5):1460-7; discussion 1467-8. doi: 10.1016/j.athoracsur.2009.01.043.

20.

Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery.

Fernandes SM, Alexander ME, Graham DA, Khairy P, Clair M, Rodriguez E, Pearson DD, Landzberg MJ, Rhodes J.

Congenit Heart Dis. 2011 Jul-Aug;6(4):294-303. doi: 10.1111/j.1747-0803.2011.00500.x. Epub 2011 Mar 21.

PMID:
21418537
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk